Merck beats by $0.06, reports revs in-line; reaffirms FY08 EPS guidance (MRK) 48.01 : Reports Q4 (Dec) earnings of $0.80 per share, excluding non-recurring items, $0.06 better than the First Call consensus of $0.74; revenues rose 3.3% year/year to $6.24 bln vs the $6.29 bln consensus.
Co reaffirms guidance for FY08, sees EPS of $3.28-3.38, excluding non-recurring items, vs. $3.37 consensus.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment